logo
NYC Gunman Blamed This Rare Brain Disease For His Mental Illness

NYC Gunman Blamed This Rare Brain Disease For His Mental Illness

Yahoo4 days ago
On Monday night, a gunman killed four people and himself in Manhattan in an attack that reportedly targeted the NFL's headquarters in the city.
The gunman, Shane Tamura, left behind a note in which he said he'd been suffering from chronic traumatic encephalopathy, or CTE, as a result of playing football. He had asked for his brain to be studied as part of CTE research.
The discourse about football's impact on the brain is not new to the NFL. Both players and their families have sued the league time and time again over the matter of brain damage and its effects on players' post-career lives.
CTE is a 'progressive neurodegenerative disease,' explained Dr. Jeremy Tanner, an assistant professor of neurology at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at UT Health San Antonio. Research shows that football players, along with other people who participate in high-contact sports and activities, are more likely to develop the disease.
A study out of Boston University's CTE Center found 40% of athletes under 30 had developed early signs of the disease upon their death. Another study out of BU found that roughly 91% of studied NFL players had the disease when they died.
Experts told HuffPost that CTE research is ongoing, but there are clear links between head injuries, behavioral changes and the disease itself. Here's what to know:
What is CTE?
Like other brain diseases, such as Alzheimer's disease or Parkinson's disease, CTE affects how we think, behave, move and 'really anything that the brain is responsible for,' said Dr. Daniel H. Daneshvar, the co-director of Mass General Brigham Sports Concussion Clinic.
'It occurs in patients that have sustained traumatic brain injury, so blows to the head that may or may not have resulted in concussions,' said Dr. Aaron S. Lord, the chief of neurology and program director for clinical research at NYU Langone Hospital–Brooklyn.
The more head injuries that occur, the higher the risk of developing chronic traumatic encephalopathy, Lord added.
The thought pattern used to be that concussions increased CTE risk, but this isn't the case, added Daneshvar.
'Concussions themselves aren't what drives CTE risk. It's a repeated traumatic brain injury to the tune of hundreds or thousands over the course of decades that... increases the risk of someone having CTE,' he said, adding that the number of traumatic brain injuries also affects the severity of the disease.
Can someone be diagnosed with CTE?
You can't walk into a doctor's office and get a diagnosis of CTE. Right now, it can only be diagnosed after death, during an autopsy, said Lord.
That means that people who may or may not have CTE can still get a gun license, a fact that can get lost in the discourse on social media about Tamura carrying the weaponry he had.
The New York Police Department reported he had a 'documented mental health history,' but it's unclear if this would restrict his gun access.
People who play contact sports are at higher risk — but any activity that involves frequent head impact is a risk factor.
Specifically, CTE has been identified in players who engage in contact sports such as football, rugby, hockey and rodeo, said Tanner, adding that it's also been seen in soccer players.
'And it seems... the more total years played, the higher the risk,' Tanner said.
It often is developed over time, after someone stops playing the sport, or the head trauma ends, explained Tanner.
Daneshvar added that 'we've also seen [it] in individuals who experience intimate partner violence, in individuals who serve in the military.'
Again, Daneshvar notes, the more often the head injury happens, the higher the risk of CTE.
'Famously, in the literature, there was a circus clown who was repeatedly shot out of a cannon and who was found to have CTE,' he said.
CTE can cause behavioral changes and memory problems.
'Chronic traumatic encephalopathy [is] typically associated with changes in cognition and in behavior,' said Tanner.
'In behavior, a common symptom is what's called neurobehavioral dysregulation. For some people, this can present as a shortened fuse or more or irritability or agitation,' Tanner said. For others, this can mean paranoia, aggression, impulse control issues and trouble regulating emotions, he added.
Neurobehavioral dysregulation tends to be more common in 'those affected by the disease in younger stages,' Tanner noted. 'Additionally, chronic traumatic encephalopathy is associated with changes in memory and with executive function, particularly planning, organization, multitasking... managing information and integrating it.'
'And those symptoms seem to be more common in older adults with the disease,' he added.
It's important to note that a lot of these symptoms can also be signs of other neurological disorders or mental health diseases, said Tanner.
In the end, individuals with a CTE diagnosis had problems with thinking, memory and behavior, said Daneshvar. But, once again, these things can be related to a multitude of other issues.
'We can't say for sure what clinical signs someone presents with are related to CTE pathology versus something else because humans are complex. We have a lot of different reasons for the way we behave,' said Daneshvar.
If you do notice mental health changes, memory issues or other neurological problems, Tanner advises people to see a specialist for an evaluation.
'It's often a neurologist or a psychiatrist or a sports medicine specialist who has expertise in evaluating those with repetitive head impacts in sports,' Tanner said. 'It can be hard to distinguish what's the primary cause, and so looking at the number of years of head impact exposure can be a clue that there could be an increased risk for CTE.'
Seeking medical attention for any neurological changes is essential, whether you're dealing with CTE or not.
'I see individuals who have histories of repeated traumatic brain injuries and are experiencing problems now, and I can't say with certainty whose problems are related to CTE versus not... but what I can do, and what I do every day, is treat them, and our treatments for people's symptoms are successful,' said Daneshvar.
While there is no cure for CTE, doctors can still help, Daneshvar noted.
'I think that's a really important message, too. I think people think that CTE is some incurable, immovable thing, right? And it is treatable.'
CTE has been linked to violence in some cases, but not always.
″In some cases, [CTE] has been linked to violent and aggressive behaviors,' Tanner said.
One of the most talked about cases of CTE is that of Aaron Hernandez, a deceased former football player who was convicted of murder.
'The short fuse, the impulse control. One way to think about it could be when you're playing sports, you can turn [your aggression] on and off. You lose that ability to control the 'on and off' switch you use to regulate your aggression when on the field and off the field,' Tanner explained.
There are some things you can do to lower your risk of CTE.
As mentioned above, people who take part in particular sports or activities, such as football and rugby, are at higher risk of CTE. But there are a few habits that can help protect your brain.
Lord added that wearing a helmet — whether that's on a bike ride or while playing football — is also an important way to protect yourself.
Tanner suggests that instead of playing tackle football, try playing flag or touch football.
'We have a lot more to learn about how to prevent this disease,' Tanner said. 'What I would suggest is trying to minimize, as much as [you're] able, head contact and head impacts.'
'For former football players and others, there's the new Diagnose CTE study that's really looking at trying to understand how we can identify these symptoms during life and better understand this disease,' Tanner said.
The study is actively recruiting former football players to learn about the unknowns of the disease.
If you or someone you know needs help, call or text 988 or chat 988lifeline.org for mental health support. Additionally, you can find local mental health and crisis resources at dontcallthepolice.com. Outside of the U.S., please visit the International Association for Suicide Prevention.
Related...
NYC Gunman Reportedly Left Note Blaming Specific Factor For His Mental Illness
Gunman Opens Fire In Manhattan Office Building, Killing 4
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

This tasty seasoning can boost memory, fight anxiety and even help prevent dementia
This tasty seasoning can boost memory, fight anxiety and even help prevent dementia

New York Post

time7 hours ago

  • New York Post

This tasty seasoning can boost memory, fight anxiety and even help prevent dementia

Herb your enthusiasm — your brain's about to get a boost. For centuries, a trusty kitchen staple has been celebrated by ancient healers for its wide-ranging medicinal properties, including sharpening memory, concentration and overall cognitive function. Now, modern science is backing up that old-school wisdom, with research suggesting the powerful plant could even help fight Alzheimer's disease, the leading cause of dementia worldwide. Advertisement 5 The herb is generally considered safe for culinary and medicinal purposes when used in moderation. rh2010 – A Mediterranean marvel Rosemary, a fragrant evergreen shrub native to the Mediterranean, has been a kitchen staple since the time of ancient Greece and Rome. Fast forward to today, and the versatile herb has won fans around the world. Its bold, aromatic leaves — whether fresh or dried — are widely used as seasoning, steeped in tea or infused into oil. Advertisement But could adding rosemary to your meals do more than just wake up your taste buds? More than just flavor Packed with phytochemicals, rosemary has been shown to help protect the body from harmful free radicals, oxidative stress and inflammation — all key drivers behind chronic illnesses like cancer, heart disease and type 2 diabetes. 5 Rosemary is part of the mint family, which also includes herbs like basil, thyme and lavender. PhotoArt Thomas Klee – It also appears to pack an antimicrobial punch, having long been used in traditional medicine to fight infections and speed wound healing. Advertisement Rosemary is a solid source of vitamins A, C and B6, along with essential minerals like iron, calcium, magnesium and potassium. It's especially rich in manganese, a key nutrient for metabolic health. With all these benefits, scientists are investigating whether rosemary could help with everything from vision and skin health to hair growth, asthma relief and even slowing the spread of cancer cells. But one of the most promising frontiers in rosemary research is the brain. Brain food since ancient times Advertisement Scientists may be just catching on, but humans have relied on rosemary to boost brainpower for thousands of years. 5 Rosemary's potent tioxidant and anti-inflammatory properties may give the brain a major boost. manassanant – Back in ancient Greece, students and scholars commonly wore garlands made from the plant on their heads during exams to boost their memory and focus. Centuries later, Shakespeare crowned it 'the herb of remembrance.' Turns out, they might have been onto something. In one study, older adults who sniffed rosemary scored significantly better on tests of prospective memory — the ability to remember to do something at the right time — compared to those in an unscented room. They were also more alert. 'This is potentially very important because prospective memory, for example, enables you to remember to take your medication at certain times of the day,' said Dr. Mark Moss, head of the department of psychology at Northumbria University, who helped lead the study. 5 The scent of rosemary has been shown to improve memory and focus, as well as lower stress and anxiety levels. annanahabed – Advertisement But it's not just seniors who could benefit. A 2018 trial found university students taking 500 mg of rosemary supplements twice daily for a month showed better memory than a placebo group. They also reported less anxiety and depression, plus better sleep — suggesting rosemary does more than just sharpen your mind. In another study, employees who drank rosemary-infused water daily said they felt less burnt out at their jobs than coworkers who didn't. Advertisement Scientists think rosemary may work its magic by boosting blood flow to the brain — flooding it with oxygen and nutrients that help clear out mental fog. Its calming scent has also been shown to lower cortisol, the body's main stress hormone. Meanwhile, research suggests its polyphenols may help fight depression by taming inflammation and supporting gut health. Rosemary also contains compounds like 1,8-cineole, which helps prevent the breakdown of acetylcholine — a key brain chemical tied to learning and memory. Experts suspect that keeping acetylcholine levels up may help your mind stay sharp with age. Advertisement 5 Over time, Alzheimer's disease gradually destroys thinking and memory skills. LIGHTFIELD STUDIOS – Researchers are also zeroing in on carnosic acid, a powerful antioxidant in rosemary that shields brain cells from damage linked to Alzheimer's disease. In 2025, researchers created a stable version called diAcCA, and early lab results are promising. The compound improved memory, strengthened brain cell connections and slashed levels of Alzheimer's-linked proteins like amyloid-beta and tau. Even better, diAcCA only activated in inflamed brain areas, potentially reducing side effects. In mouse studies, it showed no signs of toxicity and delivered major cognitive gains — raising hopes for future human trials. Advertisement The breakthrough could be big, with Alzheimer's becoming a growing public health crisis as America's population gets older. Right now, about 7.2 million Americans over 65 have the memory-robbing disease. By 2060, that number is expected to nearly double to 13.8 million unless new treatments or cures emerge.

Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition
Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition

USA Today

time21 hours ago

  • USA Today

Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition

Eagles running back Saquon Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trumps Council on Sports, Fitness, and Nutrition.' Saquon Barkley is a son, a fantastic father, the NFL's Offensive Player of the Year winner, and now a member of President Donald Trump's administration. In a move that will revive a standard from the Reagan, Clinton, and Bush era, Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.' According to the Washington Post, President Trump on Thursday announced that the presidential fitness test, a hallmark of American physical education programs, will be making a comeback in public schools. The assessment was retired and replaced by a fitness program under the Obama administration. The presidential fitness test was initiated in the 1950s by a council established by President Dwight D. Eisenhower that was directed to improve the physical fitness of American youths, in response to fears they were falling behind their European counterparts when it came to athleticism. The project is an alternative way to get anti-obesity drugs to Medicare and Medicaid patients, after the administration said in April that neither program would cover GLP-1s for weight loss. In doing so, it scrapped a 2024 Biden administration proposal for the programs to start covering GLP-1s for patients with obesity. Several high-profile athletes — all of whom have existing ties to Trump — attended the ceremony and will serve on the President's Council on Sports, Fitness and Nutrition. The attendees included professional golfer Bryson DeChambeau, who will chair the council; controversial National Football League kicker Harrison Butker; World Wrestling Entertainment mainstay Paul 'Triple H' Levesque; golfer Annika Sorenstam; and football Hall of Famer Lawrence Taylor. The Eagles running back wasn't in attendance, but will be joined by golfers Jack Nicklaus, Nelly Korda, and Gary Player (who was also awarded the Medal of Freedom alongside Sorenstam); Tony Romo, Nick Bosa, and Barkley; legendary hockey player Wayne Gretzky; and baseball player Mariano Rivera. The list also includes NFL Commissioner Roger Goodell, whom Trump repeatedly scrutinized during his first presidential term. Barkley was criticized during the off-season for spending time with President Trump on a golf outing prior to the Eagles' ring celebration.

A Doctor's Plea From a Nation Asleep on Brain Disease
A Doctor's Plea From a Nation Asleep on Brain Disease

Newsweek

timea day ago

  • Newsweek

A Doctor's Plea From a Nation Asleep on Brain Disease

Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. As a physician who once treated pain, I now endure the unimaginable. Amyotrophic lateral sclerosis (ALS) has left me quadriplegic, dependent on a tracheostomy to breathe and a feeding tube to eat. Diagnosed at 35, my career ended abruptly. My family's story reveals the scale of the coming storm—my father battles Alzheimer's, my uncle succumbed to Parkinson's, and my grandmother to Lewy body dementia. We are not outliers; we represent a silent epidemic. Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. The public's complacency is by design, built on a statistical illusion. ALS, fatal since 1869, exemplifies this peril. With a median survival of 2-3 years, it strikes about 1 in 300 people in their lifetime, which predicts that over 1 million people now alive in the U.S. will succumb to ALS. Yet, under federal law, it is labeled "rare" because that definition is based on prevalence—a static snapshot of how many people are living with a disease at one time. Because ALS kills its victims so quickly, the number of living patients stays below the 200,000-person "rare" threshold. Its very lethality ensures it is never treated like the mainstream public health crisis it is. This paradox obscures a terrifying forecast: a projected 69 percent global increase in ALS cases by 2040. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's already affects over 7 million Americans and is projected to strike nearly 13 million by 2050, costing our economy $384 billion in 2025—and projected to nearly $1 trillion annually by mid-century. Exterior view of the headquarters of the U.S. Food and Drug Administration (FDA). Exterior view of the headquarters of the U.S. Food and Drug Administration (FDA). Getty Images The failure to confront this crisis stems from a Tale of Two Agencies within the Food and Drug Administration (FDA). In 2017, Congress established the Oncology Center of Excellence (OCE), a dynamic hub that has revolutionized cancer treatment, accounting for 85 percent of all accelerated approvals in the last decade. This success is the result of focused will and resources; National Institutes of Health (NIH) funding for cancer has topped $7.2 billion, compared to $2.8 billion for neuroscience. Neurology has no such center. Lacking an institutional home, it is fragmented, slow, and characterized by a risk aversion unthinkable in oncology. This disparity persists because of the tragic nature of these diseases. In the 1980s, ACT UP activists staged "die-ins" to force a reluctant government to fight AIDS. Patients with ALS, Huntington's, or Alzheimer's cannot mount a similar protest—we are physically silenced and immobilized, unable to "seize the FDA." This vulnerability places a unique moral obligation on our leaders to act proactively on behalf of the voiceless. The new FDA leadership now arrives with bold promises of change, posing a question that haunts everyone touched by an untreatable neurological disease: Will this time be different? Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. vows to "sweep away barriers" and to "figure out new ways ... of accelerating approvals for drugs and treatments that treat rare diseases." FDA Commissioner Marty Makary has several times asked why it takes 10 years for a drug to get to market and proposes a "conditional approval" pathway based on a "plausible mechanism." Center for Biologics Evaluation and Research (CBER) Director Vinay Prasad promised to "take action at the first sign of promise for rare diseases." For the ALS community, these words are now a crisis of credibility. In a disease that has a median survival of 2-3 years, we are asking for regulatory flexibility for a treatment that began its Phase 1 trial in 2011 and was granted FDA Fast Track designation in 2014. As a petitioner on the July 3 citizens' petition for a stem cell therapy known as NurOwn, my community has presented the FDA with a clear test. Ultimately, we are seeking accelerated approval based on new, unprecedented survival data from an expanded access program—data that exceeds the extension of survival of many approved cancer therapies. But the initial request is simpler: invite the sponsor to resubmit its application for a full review. Ours is a request for due process to give a voice to the voiceless—the lowest possible bar for the Trump administration to demonstrate its promised flexibility. A clear, bipartisan solution has already failed once. The Neuroscience Center of Excellence Act, introduced in 2021 to replicate oncology's success for brain disease, stalled in committee. It is time for our leaders to find the political will that has been so catastrophically absent. Congress must immediately revive and pass the Neuroscience Center of Excellence Act. The FDA, in turn, must match its leaders' promises with action by granting our petition a review. The science is poised for breakthroughs, but it is being shackled by a broken system. For those of us on a deadline, this is not a policy debate. It is a death sentence. Awaken now, before this silent storm engulfs us all. The voiceless can't wait. Dr. Shahriar Minokadeh, a former anesthesiologist trained at Johns Hopkins and pain management at UC San Diego, types via an eye-gaze device. The views expressed in this article are the writer's own.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store